Jane Street’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Jane Street’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-16,300	Closed	-$448K	–	9842
2024 Q4	$448K	Buy	+16,300	New	+$454K	﹤0.01%	7009
2022 Q2	–	Sell	-28,100	Closed	-$1.74M	–	10081
2022 Q1	$1.74M	Buy	+28,100	New	+$1.72M	﹤0.01%	5018
2021 Q4	–	Sell	-4,000	Closed	-$210K	–	10339
2021 Q3	$210K	Sell	4,000 -1,700	-30%	-$101K	﹤0.01%	8768
2021 Q2	$393K	Sell	5,700 -23,000	-80%	-$1.75M	﹤0.01%	7695
2021 Q1	$2.21M	Sell	28,700 -29,300	-51%	-$2.7M	﹤0.01%	3828
2020 Q4	$5.74M	Sell	58,000 -1,500	-3%	-$183K	﹤0.01%	1968
2020 Q3	$8.44M	Buy	+59,500	New	+$9.92M	0.01%	1356

Other funds holding LKFT

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

DCM

DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Jane Street's LKFT Position: Q2 2026 in Review

Jane Street sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2026, closing a stake of 13,607 shares — an estimated $408K sold.

Jane Street first reported a position in LKFT in Q3 2015 and held it in 28 quarters. The position peaked at $20.8M in Q3 2018. 76 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

Jane Street reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2026 after selling out during the quarter.
Jane Street sold 13,607 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $408K.
Jane Street first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2015 and held it in 28 quarters.
Jane Street's Lakefront Biotherapeutics American Depositary Shares position peaked at $20.8M in Q3 2018.
76 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.